Primary malignant melanoma of the lung: A case report

por Yamamoto, Yoko, Kodama, Ken, Maniwa, Tomohiro, Takeda, Masashi, Tanaka, Yuuka, Ozawa, Kentaro, Isei, Taiki
Publicado 2017

A phase I study of the safety and efficacy of talimogene laherparepvec in Japanese patients with advanced melanoma

por Yamazaki, Naoya, Isei, Taiki, Kiyohara, Yoshio, Koga, Hiroshi, Kojima, Takashi, Takenouchi, Tatsuya, Yokota, Kenji, Namikawa, Kenjiro, Yi, Min, Keegan, Alissa, Fukushima, Satoshi
Publicado 2022

Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma

por Yamazaki, Naoya, Kiyohara, Yoshio, Uhara, Hisashi, Iizuka, Hajime, Uehara, Jiro, Otsuka, Fujio, Fujisawa, Yasuhiro, Takenouchi, Tatsuya, Isei, Taiki, Iwatsuki, Keiji, Uchi, Hiroshi, Ihn, Hironobu, Minami, Hironobu, Tahara, Hideaki
Publicado 2017

Efficacy and safety of Infliximab for steroid-resistant immune-related adverse events: A retrospective study

por Kadokawa, Yukio, Takagi, Mari, Yoshida, Tomoe, Tatsumi, Akitoshi, Fujita, Keiko, Inoue, Takako, Ohe, Shuichi, Nakai, Yasutomo, Yamamoto, Sachiko, Otsuka, Tomoyuki, Ishihara, Ryu, Isei, Taiki, Kumagai, Toru, Nishimura, Kazuo, Imamura, Fumio
Publicado 2021

Efficacy and safety of mycophenolate mofetil in treating immune‐related hepatitis induced by immune checkpoint inhibitor use: A retrospective study

por Kadokawa, Yukio, Inoue, Satoko, Tatsumi, Akitoshi, Uchida, Mayako, Fujita, Keiko, Takagi, Mari, Inoue, Takako, Ohe, Shuichi, Nakai, Yasutomo, Otsuka, Tomoyuki, Abe, Yutaro, Nakabori, Tasuku, Isei, Taiki, Kumagai, Toru, Nishimura, Kazuo, Ohkawa, Kazuyoshi
Publicado 2023

Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study

por Nishikawa, Tatsuya, Inoue, Takako, Otsuka, Tomoyuki, Kuno, Ikumi, Kukita, Yoji, Nakamura, Harumi, Ikeda, Yoshihiko, Yasui, Taku, Shioyama, Wataru, Oka, Toru, Honma, Keiichirou, Hatakeyama, Kinta, Miyata, Hiroshi, Isei, Taiki, Ishihara, Ryu, Kumagai, Toru, Nishimura, Kazuo, Fujita, Masashi
Publicado 2022

Efficacy of salvage therapies for advanced acral melanoma after anti-PD-1 monotherapy failure: a multicenter retrospective study of 108 Japanese patients

por Mori, Tatsuhiko, Namikawa, Kenjiro, Yamazaki, Naoya, Kiniwa, Yukiko, Yamasaki, Osamu, Yoshikawa, Shusuke, Inozume, Takashi, Kato, Hiroshi, Nakai, Yasuo, Fukushima, Satoshi, Takenouchi, Tatsuya, Maekawa, Takeo, Matsushita, Shigeto, Otsuka, Atsushi, Nomura, Motoo, Baba, Natsuki, Isei, Taiki, Saito, Shintaro, Fujimoto, Noriki, Tanaka, Ryo, Kaneko, Takahide, Kuwatsuka, Yutaka, Matsuya, Taisuke, Nagase, Kotaro, Onishi, Masazumi, Onuma, Takehiro, Nakamura, Yasuhiro
Publicado 2023

Systemic therapy for Asian patients with advanced BRAF V600‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (B‐CHECK‐RWD study)

por Namikawa, Kenjiro, Ito, Takamichi, Yoshikawa, Shusuke, Yoshino, Koji, Kiniwa, Yukiko, Ohe, Shuichi, Isei, Taiki, Takenouchi, Tatsuya, Kato, Hiroshi, Mizuhashi, Satoru, Fukushima, Satoshi, Yamamoto, Yosuke, Inozume, Takashi, Fujisawa, Yasuhiro, Yamasaki, Osamu, Nakamura, Yasuhiro, Asai, Jun, Maekawa, Takeo, Funakoshi, Takeru, Matsushita, Shigeto, Nakano, Eiji, Oashi, Kohei, Kato, Junji, Uhara, Hisashi, Miyagawa, Takuya, Uchi, Hiroshi, Hatta, Naohito, Tsutsui, Keita, Maeda, Taku, Matsuya, Taisuke, Yanagisawa, Hiroto, Muto, Ikko, Okumura, Mao, Ogata, Dai, Yamazaki, Naoya
Publicado 2023